Insulin versus insulin plus sulfonylureas in type 2 diabetic patients with secondary failure to sulfonylureas

This publication has 20 references indexed in Scilit:

• PHYSIOLOGICAL BASIS OF THE EFFECTIVENESS OF COMBINED INSULIN-TOLBUTAMIDE THERAPY IN STABLE DIABETES*
  Annals of the New York Academy of Sciences, 2006
• Effects of the combination of insulin and glibenclamide in Type 2 (non-insulin-dependent) diabetic patients with secondary failure to oral hypoglycaemic agents
  Diabetologia, 1988
• Combined Therapy of Insulin and Tolazamide Decreases Insulin Requirement and Serum Triglycerides in Obese Patients with Noninsulin-Dependent Diabetes Mellitus
  The Lancet Healthy Longevity, 1987
• Addition of sulfonylurea to insulin treatment in poorly controlled type II diabetes. A double-blind, randomized clinical trial
  JAMA, 1987
• Clinical pharmacology of sulfonylureas
  Metabolism, 1987
• Insulin and a sulfonylurea agent in non-insulin-dependent diabetes mellitus
  Archives of internal medicine (1960), 1986
• Glyburide in non-insulin-dependent diabetes. Its therapeutic effect in patients with disease poorly controlled by insulin alone
  Archives of internal medicine (1960), 1985
• The combination of insulin and sulphonylurea in the treatment of secondary drug failure in patients with type II diabetes
  Acta Endocrinologica, 1984
• New concepts in the pathogenesis and treatment of noninsulin-dependent diabetes mellitus
  The American Journal of Medicine, 1983
• Use of Tolbutamide in Insulin-Resistant Diabetes
  New England Journal of Medicine, 1957